Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
Files
Publication date
2016-12
Authors
Adams, Hugo J A
Kwee, Thomas C.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, General Medicine, Radiology Nuclear Medicine and imaging, Letter
Citation
Adams, H J A & Kwee, T C 2016, 'Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?', Nuclear Medicine Communications, vol. 37, no. 12, pp. 1333–1334. https://doi.org/10.1097/MNM.0000000000000584